Hepatitis B Therapy

Regimens altering lamivudine and interferon yield similar results in children

Published in Hepatitis Weekly, September 23rd, 2002

by Sonia Nichols, senior medical writer - Pediatric patients with hepatitis B virus (HBV) tend to respond to therapy that combines lamivudine and interferon without regard to the way the therapies are combined, according to a new study.

Still, the report's authors are recommending more pediatric studies that would discern whether any additional benefits could be derived from having children receive interferon or lamivudine first, last, or at the same time when they begin treatment regimens.

In the October 2002 edition of Journal of Gastroenterology and Hepatology, Bunyamin Dikici and colleagues reported the results of a pediatric hepatitis B...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-09-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry